Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Century Therapeutics

Request full access

Developing novel allogeneic iPSC-derived natural killer (NK) and T cell products with the potential to overcome many limitations of earlier generation cell therapies

Philadelphia, United StatesFounded 2018Biotech & Life Sciences

About Century Therapeutics

Century Therapeutics, Inc. is a pioneering biotechnology company focused on developing transformative allogeneic cell therapies. These therapies are designed to treat both hematological (blood-related) and solid tumor malignancies, addressing significant unmet medical needs in the healthcare sector. The company leverages a comprehensive allogeneic cell therapy platform that includes industry-leading induced pluripotent stem cells (iPSCs), advanced differentiation techniques to generate immune effector cells from iPSCs, and CRISPR-mediated precision gene editing. Century Therapeutics operates primarily in the biotechnology and healthcare markets, serving patients with severe cancer conditions. The business model revolves around research and development (R&D) of innovative therapies, which are then brought to market through clinical trials and regulatory approvals. Revenue is generated through partnerships, licensing agreements, and eventual commercialization of successful therapies.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2021
Employees
121
Open positions
6
Dealroom signal
29.1/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Oncology, Rumoured $1B, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Investment activity
1 company, latest Apr 2024
Capital deployed
—
Preferred round
ACQUISITION

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
PRIVATE PLACEMENT VCOther financing Jan 2026 $135M — Venrock · JDRF T1D Fund · RTW Investments · TCGX ↗
PRIVATE PLACEMENT VCOther financing Apr 2024 $60M — Adage Capital · Casdin Capital · Octagon Capital Partners · Superstring Capital ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Century Therapeutics website traffic

Latest recorded traffic for Century Therapeutics is 5.8K monthly website visits, up 11.5% over the last three months. Century Therapeutics's team grew 15.2% over the past year.

Latest monthly visits5.8K 3-month web change+11.5% 1-year team growth+15.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Century Therapeutics in the Philadelphia ecosystem

Live from Dealroom

The Century Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

26 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later11 investors entered at this stage

Other known investors12 additional known investors

  • Adage Capital
  • Bain Capital Life Sciences
  • Boxer Capital
  • Commodore Capital
  • Dafna Capital Management
  • Deep Track Capital
  • JDRF T1D Fund
  • RTW Investments
  • Superstring Capital
  • TCGX
  • Venrock
  • Venrock Healthcare Capital Partners
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States98%
🇨🇦 Canada2%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Century Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Century Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.